A meta‐analysis including 11 retrospective studies with 1839 RCCs found no difference between AR expression and metastatic status, metastatic type (lymph or distant metastasis), susceptibility, pathological type or cancer‐specific survival of RCC. The gene discussed is AR; the disease is renal cell carcinoma.